RELMADA THERAPEUTICS, INC. Bonus & Incentive Agreements
11 Contracts & Agreements
- Relmada Therapeutics, Inc. 2021 Equity Incentive Plan, as amended (Filed With SEC on May 25, 2023)
- Relmada Therapeutics, Inc. 2021 Equity Incentive Plan, as amended (Filed With SEC on June 1, 2022)
- Relmada Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on May 20, 2021)
- Relmada Therapeutics, Inc., 2021 Equity Incentive Plan (Filed With SEC on March 24, 2021)
- Amendment No. 5 to the Relmada Therapeutics, Inc. 2014 Stock Option and Equity Incentive Plan, as amended (Filed With SEC on March 9, 2020)
- Amendment No. 4 to the Relmada Therapeutics, Inc. 2014 Stock Option and Equity Incentive Plan, as amended (Filed With SEC on May 15, 2019)
- Third Amendment to the 2014 Stock Option and Equity Incentive Plan, as amended (Filed With SEC on May 14, 2018)
- AMENDMENT NO. 2 TO RELMADA THERAPEUTICS, INC. 2014 STOCK OPTION AND EQUITY INCENTIVE PLAN, AS AMENDED (Filed With SEC on February 10, 2017)
- RELMADATHERAPEUTICS, INC. FIRSTAMENDMENT TO THE 2014 STOCK OPTION AND EQUITY INCENTIVE PLAN (Filed With SEC on August 7, 2015)
- RelmadaTherapeutics, Inc. 2014STOCK OPTION AND EQUITY INCENTIVE PLAN SECTION1. PURPOSE (Filed With SEC on December 9, 2014)
- Relmada Therapeutics, Inc. 2012 STOCK OPTION AND EQUITY INCENTIVE PLAN SECTION 1. PURPOSE (Filed With SEC on May 27, 2014)
